Logo-ipp

Immunopathol Persa. 2021;7(2): e19. doi: 10.34172/ipp.2021.19

Original

Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran

Mohsen Seddigh-Shamsi 1 ORCID, Shima Nabavi Mahali 2 ORCID, Mahnaz Mozdourian 3 ORCID, Abolghasem Allahyari 1 ORCID, Neda Saeedian 2 ORCID, Maryam Emadzade 4, Farnoosh Ebrahimzadeh 2 ORCID, Zahra Javidarabshahi 3 ORCID, Shohre Khatami 2 ORCID, Mina Akbari Rad 2 ORCID, Sahar Ravanshad 2 ORCID, Maryam Naghavi 5 ORCID, Zahra Mozaheb 1 ORCID, Mohammad Moeini Nodeh 1 ORCID, Hossein Rahimi 1 ORCID, Alireza Bary 1, Mostafa Kamandi 1 ORCID, Sajad Ataei Azimi 1 ORCID, Mohammad Ali Yaghoubi 6 ORCID, Zahra Rezaei Borojerdi 1 * ORCID

Cited by CrossRef: 4

1- Heydarian M, Mohammadtaghizadeh M, Shojaei M, Babazadeh M, Abbasian S, Amrovani M. The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword. Mol Biol Rep. 2022;49(1):605 [Crossref]
2- Safdari H, Bagheri S, Talkhi N, Saberi Teymourian E, Hosseini Bafghi M, Ahmadi M. Cq values as an indicator for COVID‐19 outcomes: A study of the correlation between laboratory parameters. Immunity Inflam & Disease. 2024;12(6) [Crossref]
3- Petelina T, Musikhina N, Avdeeva K, Shcherbinina A, Leonovich S, Zueva E, Garanina V, Gultiaeva E, Yaroslavskaya E, Kalyuzhnaya E, Gorbatenko E, Kapustina A, Gapon L. Estimation of erythrocyte parameters of general blood analysis in patients with SARS-CoV-2 -associated pneumonia. Klin lab diagn. 2022;67(1):24 [Crossref]
4- Aghaamini Fashami A, Sayadi M, Miri Moghaddam E. Coagulation Disorder’s in SARS-CoV-2 Patients. Zahedan J Res Med Sci. 2022;25(1) [Crossref]